Literature DB >> 16730047

Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.

Margaret A Wheatley1, Flemming Forsberg, Kelleny Oum, Raymond Ro, Dalia El-Sherif.   

Abstract

A comparison between in vitro and in vivo experiments conducted to investigate the acoustic properties of a novel, 1.2 microm diameter poly(lactic-co-glycolic acid) (50:50) (PLGA) ultrasound contrast agent, the development of which was described previously by us, is presented. A pulse-echo setup was used to determine enhancement in vitro. Additional in vitro studies further characterized the hollow microcapsules, including resonance frequency from attenuation measurements (from 2.25 to 15 MHz) and temperature effects (25 degrees C vs. 37 degrees C). In vivo, four rabbits received intravenous injections of the agent (dose range: 0.005-0.13 ml/kg). Quantitative in vivo dose-responses were calculated off-line using spectral power analysis of audio Doppler signals acquired from a custom-made 10 MHz cuff transducer placed around the surgically exposed distal aorta. This frequency was chosen since the very shallow scanning depths encountered in rabbits, in particular for the cuff transducer placed directly around the vessel, necessitates the use of high frequency imaging devices with sufficient spatial resolution to enable meaningful measurements. For qualitative assessments, two rabbits were imaged pre- and post-contrast administration (dose: 0.1 ml/kg) in power Doppler mode. Significant acoustic enhancements (up to 24 dB) were reported both in vitro and in vivo. Moreover, the rabbits did not show any adverse side effects from multiple injections (>20) of the agent. Measured in vitro resonance frequency between 3.09 and 3.49 MHz was lower than predicted for a similar sized free bubble, potentially due to capsule wall structure. Minimal loss of signal (approximately 4 dB) was observed at 25 degrees C over 20 min of insonation at 5 MHz but at 37 degrees C the signal dropped close to base line within the first 5 min. This temperature sensitivity could be due to loss of capsule integrity (and hence loss of gas). Potential causes include increased hydrolysis or polymer softening and increased water uptake by the shell at temperatures closer to the glass transition temperature (T(g)).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730047     DOI: 10.1016/j.ultras.2006.04.003

Source DB:  PubMed          Journal:  Ultrasonics        ISSN: 0041-624X            Impact factor:   2.890


  20 in total

Review 1.  In vitro methods to study bubble-cell interactions: Fundamentals and therapeutic applications.

Authors:  Guillaume Lajoinie; Ine De Cock; Constantin C Coussios; Ine Lentacker; Séverine Le Gac; Eleanor Stride; Michel Versluis
Journal:  Biomicrofluidics       Date:  2016-01-28       Impact factor: 2.800

Review 2.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 3.  Ultrasound imaging beyond the vasculature with new generation contrast agents.

Authors:  Reshani H Perera; Christopher Hernandez; Haoyan Zhou; Pavan Kota; Alan Burke; Agata A Exner
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-08

Review 4.  Phase-shift, stimuli-responsive drug carriers for targeted delivery.

Authors:  Brian E O'Neill; Natalya Rapoport
Journal:  Ther Deliv       Date:  2011-09

5.  Scavenging dissolved oxygen via acoustic droplet vaporization.

Authors:  Kirthi Radhakrishnan; Christy K Holland; Kevin J Haworth
Journal:  Ultrason Sonochem       Date:  2016-01-19       Impact factor: 7.491

6.  Preserving the Integrity of Surfactant-Stabilized Microbubble Membranes for Localized Oxygen Delivery.

Authors:  Brian E Oeffinger; Purva Vaidya; Iman Ayaz; Rawan Shraim; John R Eisenbrey; Margaret A Wheatley
Journal:  Langmuir       Date:  2019-03-14       Impact factor: 3.882

7.  Subcritical CO2 sintering of microspheres of different polymeric materials to fabricate scaffolds for tissue engineering.

Authors:  Manjari Bhamidipati; BanuPriya Sridharan; Aaron M Scurto; Michael S Detamore
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-08-15       Impact factor: 7.328

8.  Plasma sterilization of poly lactic acid ultrasound contrast agents: surface modification and implications for drug delivery.

Authors:  John R Eisenbrey; Jennifer Hsu; Margaret A Wheatley
Journal:  Ultrasound Med Biol       Date:  2009-09-19       Impact factor: 2.998

9.  Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents.

Authors:  J R Eisenbrey; P Huang; J Hsu; M A Wheatley
Journal:  Ultrasonics       Date:  2009-03-28       Impact factor: 2.890

10.  Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging.

Authors:  Natalya Rapoport; Anne M Kennedy; Jill E Shea; Courtney L Scaife; Kweon-Ho Nam
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.